Entrada Therapeutics Inc (TRDA)
13.52
+0.36
(+2.77%)
USD |
NASDAQ |
May 06, 16:00
14.00
+0.48
(+3.51%)
After-Hours: 20:00
Entrada Therapeutics Market Cap: 454.45M for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 442.19M |
| May 02, 2024 | 455.63M |
| May 01, 2024 | 445.21M |
| April 30, 2024 | 398.17M |
| April 29, 2024 | 414.64M |
| April 26, 2024 | 418.33M |
| April 25, 2024 | 415.31M |
| April 24, 2024 | 417.66M |
| April 23, 2024 | 433.12M |
| April 22, 2024 | 440.17M |
| April 19, 2024 | 408.25M |
| April 18, 2024 | 400.19M |
| April 17, 2024 | 410.61M |
| April 16, 2024 | 427.41M |
| April 15, 2024 | 433.12M |
| April 12, 2024 | 435.13M |
| April 11, 2024 | 445.55M |
| April 10, 2024 | 420.69M |
| April 09, 2024 | 446.22M |
| April 08, 2024 | 451.93M |
| April 05, 2024 | 464.03M |
| April 04, 2024 | 464.70M |
| April 03, 2024 | 464.03M |
| April 02, 2024 | 466.38M |
| April 01, 2024 | 462.35M |
| Date | Value |
|---|---|
| March 28, 2024 | 476.13M |
| March 27, 2024 | 482.18M |
| March 26, 2024 | 462.35M |
| March 25, 2024 | 449.58M |
| March 22, 2024 | 461.01M |
| March 21, 2024 | 454.96M |
| March 20, 2024 | 448.57M |
| March 19, 2024 | 426.73M |
| March 18, 2024 | 416.99M |
| March 15, 2024 | 429.42M |
| March 14, 2024 | 409.93M |
| March 13, 2024 | 427.07M |
| March 12, 2024 | 389.10M |
| March 11, 2024 | 395.15M |
| March 08, 2024 | 426.06M |
| March 07, 2024 | 422.70M |
| March 06, 2024 | 416.32M |
| March 05, 2024 | 410.61M |
| March 04, 2024 | 413.95M |
| March 01, 2024 | 459.09M |
| February 29, 2024 | 442.38M |
| February 28, 2024 | 434.35M |
| February 27, 2024 | 456.42M |
| February 26, 2024 | 462.10M |
| February 23, 2024 | 446.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.20M
Minimum
May 09 2022
1.094B
Maximum
Nov 17 2021
456.12M
Average
456.57M
Median
Market Cap Benchmarks
| GlycoMimetics Inc | 20.24M |
| Lyell Immunopharma Inc | 644.13M |
| Candel Therapeutics Inc | 260.90M |
| Eliem Therapeutics Inc | 237.00M |
| NovaBay Pharmaceuticals Inc | 2.751M |
Market Cap Related Metrics
| PS Ratio | 3.504 |
| Price to Book Value | 1.875 |
| Price to Free Cash Flow | 3.369 |
| Price | 13.52 |
| Earnings Yield | -1.92% |